AB Science S.A. (OTCMKTS:ABSCF – Get Free Report) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 21,788 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
AB Science Stock Performance
ABSCF stock opened at $1.12 on Friday. AB Science has a fifty-two week low of $1.12 and a fifty-two week high of $1.37. The stock has a fifty day moving average of $1.12 and a 200-day moving average of $1.17.
About AB Science
AB Science is a France-based biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for human and veterinary medicine. The company’s research centers on tyrosine kinase inhibitors, a class of medicines designed to modulate signaling pathways involved in cancer, inflammation and other diseases.
Its lead product is masitinib, an orally administered tyrosine kinase inhibitor that targets pathways involving mast cells and certain other immune and tumor-related cells.
See Also
- Five stocks we like better than AB Science
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for AB Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Science and related companies with MarketBeat.com's FREE daily email newsletter.
